Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Poissonnet

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2020
Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric studyDorian Culié, Julien Viotti, Anouchka Modesto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 4, 2021
Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric studyDorian Culié, Renaud Schiappa, Anouchka Modesto, et al.
Oral Oncology|October 31, 2020
Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
Oral Oncology|September 9, 2021
Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2018
Predicting early death in older adults with cancerRabia Boulahssass, Sebastien Gonfrier, Jean-Marc Ferrero, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2020
Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric studyDorian Culié, Quentin Lisan, Charlotte Leroy, et al.
Oral Oncology|October 21, 2024
Therapeutic strategy for advanced stages salivary carcinomas of the tongue: A multicenter REFCOR studyValentine Poissonnet, Emilien Chabrillac, Emmanuelle Uro-Coste, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 29, 2026
Intratumoral Radioenhancer Nanoparticle NBTXR3 Followed by Radiotherapy in Head and Neck Cancer: A Phase 1 Dose-Expansion Nonrandomized Clinical TrialChristophe Le Tourneau, Xavier Liem, France Nguyen, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2020
Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric studyDorian Culié, Julien Viotti, Anouchka Modesto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 4, 2021
Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric studyDorian Culié, Renaud Schiappa, Anouchka Modesto, et al.
Oral Oncology|October 31, 2020
Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
Oral Oncology|September 9, 2021
Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric studyFlorent Milliet, Alexandre Bozec, Renaud Schiappa, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2018
Predicting early death in older adults with cancerRabia Boulahssass, Sebastien Gonfrier, Jean-Marc Ferrero, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2020
Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric studyDorian Culié, Quentin Lisan, Charlotte Leroy, et al.
Oral Oncology|October 21, 2024
Therapeutic strategy for advanced stages salivary carcinomas of the tongue: A multicenter REFCOR studyValentine Poissonnet, Emilien Chabrillac, Emmanuelle Uro-Coste, et al.
JAMA Otolaryngology-- Head & Neck Surgery|January 29, 2026
Intratumoral Radioenhancer Nanoparticle NBTXR3 Followed by Radiotherapy in Head and Neck Cancer: A Phase 1 Dose-Expansion Nonrandomized Clinical TrialChristophe Le Tourneau, Xavier Liem, France Nguyen, et al.
Pageof 10